Fengyan Jin

This study looks at a three-drug combination (daratumumab, pomalidomide, and dexamethasone) for people with multiple myeloma that has come back after first treatment. About 50 adults will take part to see how well the drugs control the cancer and delay further relapse. The goal i…

This study tests a treatment plan that adjusts based on each patient's frailty level for elderly people newly diagnosed with multiple myeloma. The goal is to see if tailoring therapy can improve response rates and reduce treatment side effects. About 131 participants aged 65 and …